- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
Patent holdings for IPC class A61K 47/54
Total number of patents in this class: 7144
10-year publication summary
|
143
|
252
|
458
|
573
|
579
|
729
|
820
|
866
|
945
|
835
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 1143 |
106 |
| The Regents of the University of California | 20315 |
91 |
| Purdue Research Foundation | 3739 |
80 |
| Dana-Farber Cancer Institute, Inc. | 2629 |
79 |
| Massachusetts Institute of Technology | 10161 |
69 |
| Sapreme Technologies B.V. | 89 |
60 |
| Northwestern University | 3465 |
57 |
| Yale University | 2449 |
55 |
| Modernatx, Inc. | 1287 |
43 |
| Arrowhead Pharmaceuticals, Inc. | 321 |
42 |
| Arvinas Operations, Inc. | 244 |
42 |
| City of Hope | 1014 |
37 |
| Ionis Pharmaceuticals, Inc. | 920 |
37 |
| Novartis AG | 10595 |
36 |
| Centre National de La Recherche Scientifique | 10716 |
36 |
| Novo Nordisk A/S | 2284 |
36 |
| The Johns Hopkins University | 5759 |
35 |
| University of Massachusetts | 2264 |
34 |
| Kymera Therapeutics, Inc. | 244 |
31 |
| SeaGen Inc | 596 |
30 |
| Other owners | 6108 |